Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategies

Global spread of coronavirus disease 2019 (COVID-19) has created an unprecedented infectious disease crisis worldwide. Despite uncertainties about COVID-19, model-based forecasting of competing mitigation measures on its course is urgently needed to inform mitigation policy. We used a stochastic agent-based microsimulation model of the COVID-19 epidemic in New York City and evaluated the potential impact of quarantine duration (from 4 to 16 weeks), quarantine lifting type (1-step lifting for all individuals versus a 2-step lifting according to age), post-quarantine screening, and use of a hypothetical effective treatment against COVID-19 on the disease's cumulative incidence and mortality, and on ICU-bed occupancy. The source code of the model has been deposited in a public source code repository. The model calibrated well and variation of model parameter values had little impact on outcome estimates. While quarantine is efficient to contain the viral spread, it is unlikely to prevent a rebound of the epidemic once lifted. We projected that lifting quarantine in a single step for the full population would be unlikely to substantially lower the cumulative mortality, regardless of quarantine duration. By contrast, a two-step quarantine lifting according to age was associated with a substantially lower cumulative mortality and incidence, up to 71% and 23%, respectively, as well as lower ICU-bed occupancy. Although post-quarantine screening was associated with diminished epidemic rebound, this strategy may not prevent ICUs from being overcrowded. It may even become deleterious after a 2-step quarantine lifting according to age if the herd immunity effect does not had sufficient time to become established in the younger population when the quarantine is lifted for the older population. An effective treatment against COVID-19 would considerably reduce the consequences of the epidemic, even more so if ICU capacity is not exceeded.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  Aravind Srinivasan,et al.  Modelling disease outbreaks in realistic urban social networks , 2004, Nature.

[3]  Reuben Samuel,et al.  Herd immunity and herd effect: new insights and definitions , 2004, European Journal of Epidemiology.

[4]  S. Riley.  Large-Scale Spatial-Transmission Models of Infectious Disease , 2007, Science.

[5]  Bud Mishra,et al.  Modeling and simulation of e-mail social networks: A new stochastic agent-based approach , 2008, 2008 Winter Simulation Conference.

[6]  Horst Rinne,et al.  The Weibull Distribution: A Handbook , 2008 .

[7]  Joshua M. Epstein,et al.  Modelling to contain pandemics , 2009, Nature.

[8]  Alessandro Vespignani,et al.  Comparing large-scale computational approaches to epidemic modeling: Agent-based versus structured metapopulation models , 2010, BMC infectious diseases.

[9]  K. Karahalios,et al.  The Network in the Garden: Designing Social Media for Rural Life , 2010 .

[10]  T. Déirdre Hollingsworth,et al.  Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives , 2011, PLoS Comput. Biol..

[11]  Andrew Crooks,et al.  Introduction to Agent-Based Modelling , 2012 .

[12]  Ali Bazghandi,et al.  Techniques, Advantages and Problems of Agent Based Modeling for Traffic Simulation , 2012 .

[13]  Andrew Crooks,et al.  Agent-based Models of Geographical Systems , 2012 .

[14]  Michael F. Green,et al.  Social Disconnection in Schizophrenia and the General Community , 2018, Schizophrenia bulletin.

[15]  Vito Latora,et al.  Simplicial models of social contagion , 2018, Nature Communications.

[16]  Haoyang Sun,et al.  Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study , 2020, The Lancet Infectious Diseases.

[17]  Centers for Disease Control and Prevention CDC COVID-19 Response Team.  Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[18]  D. Adam.  Special report: The simulations driving the world’s response to COVID-19 , 2020, Nature.

[19]  Yonatan H. Grad,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[20]  John S. Brownstein,et al.  Epidemiological data from the COVID-19 outbreak, real-time case information , 2020, Scientific Data.

[21]  Célia Michotey,et al.  The GenTree Dendroecological Collection, tree-ring and wood density data from seven tree species across Europe , 2020, Scientific Data.

[22]  Carl A. B. Pearson,et al.  The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.

[23]  M. Lipsitch,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[24]  Yang Liu,et al.  Early dynamics of transmission and control of COVID-19: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[25]  T. Hollingsworth,et al.  How will country-based mitigation measures influence the course of the COVID-19 epidemic? , 2020, The Lancet.

[26]  Syed Faraz Ahmed,et al.  Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies , 2020, Viruses.

[27]  J. Rocklöv,et al.  The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.

[28]  Q. Tao,et al.  Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.

[29]  Immunity length will be key for COVID-19 outlook , 2020, Emerald Expert Briefings.

[30]  Sanyi Tang,et al.  The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China , 2020, International Journal of Infectious Diseases.

[31]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[32]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[33]  C. Whittaker,et al.  Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .

[34]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[35]  Don Klinkenberg,et al.  Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[36]  G. Lippi,et al.  Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) , 2020, Respiratory Medicine.

[37]  Nicholas P Jewell,et al.  Predictive Mathematical Models of the COVID-19 Pandemic: Underlying Principles and Value of Projections. , 2020, JAMA.

[38]  P. Klepac,et al.  The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China , 2020, medRxiv.

[39]  C. Vardavas,et al.  COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.